Keros Therapeutics
KROS
KROS
107 hedge funds and large institutions have $731M invested in Keros Therapeutics in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $901M → $731M (-$170M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
80% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 20
Holders
107
Holding in Top 10
2
Calls
$1.67M
Puts
$3K
Top Buyers
| 1 | +$14M | |
| 2 | +$12.7M | |
| 3 | +$7.1M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$6.8M |
| 5 |
Millennium Management
New York
|
+$5.23M |
Top Sellers
| 1 | -$14.5M | |
| 2 | -$12M | |
| 3 | -$6.37M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$5.37M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.63M |